News

Moderna, COVID-19

EU regulator backs Moderna's updated COVID vaccine
The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday. The updated shot targets the LP.8.1 variant,
Moderna’s updated COVID-19 vaccine receives positive EMA opinion
Moderna has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use for its updated COVID-19 vaccine targeting the SARS-CoV-2 variant LP.8.1.
Moderna’s latest approval again reveals FDA rift over COVID vaccines
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.
Pfizer, BioNTech Get CHMP Backing for Updated Covid-19 Vaccine
Pfizer and BioNTech said a key European regulatory committee recommended approval of an updated version of their updated Comirnaty Covid-19 vaccine that targets the LP.8.1 strain. The companies on Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers the LP.
Pfizer/BioNTech, Moderna win EU backing for updated COVID shots
An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations for COVID-19 shots developed by Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) targeting the LP.
BioSpace7d
After Moderna Pulled Its Shot, Combination Flu/COVID Vaccines Hang in Limbo
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?
MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...
What's Going On With Moderna Stock Wednesday?
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...
CBS News3y
Moderna asks FDA to authorize its COVID vaccine for children ages 5 and ...
Moderna says it has formally submitted a request to the Food and Drug Administration for authorization of two doses of its COVID-19 vaccine in children younger than 6 years old, kicking off a ...
Science News4y
How the FDA-authorized Moderna COVID-19 vaccine compares to Pfizer’s ...
A second coronavirus vaccine has now joined the fight against COVID-19 in the United States. On December 18, the U.S. Food and Drug Administration authorized Moderna’s vaccine for emergency ...
Time4y
Moderna’s COVID-19 Vaccine Is 94.5% Effective. Here’s What That ...
Pfizer reported its mRNA vaccine was more than 90% effective in protecting against COVID-19 disease, but it’s important to understand what effectiveness means in their and Moderna’s studies.
CBS News4y
Moderna says its COVID-19 vaccine highly effective in late trial
Investors were seemingly buoyed by Moderna's vaccine trial results, with U.S. stock futures on Monday pointing to a strong opening. Dow futures were up 476 points, or 1.6%, before the start of ...
Forbes4y
What You Need To Know About Moderna’s Covid-19 Vaccine - Forbes
Moderna’s Covid-19 vaccine is an mRNA vaccine that relies on messenger RNA to deliver instructions to the cells in your body, which then produce small parts of the Covid-19 virus that are ...
Science News4y
Moderna says its COVID-19 vaccine is nearly 95 percent effective
Moderna Inc. Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study. Posted online November 16, 2020.
inews.co.uk on MSN1d
Covid vaccine pandemic stockpile running low – with £375m-worth of new jabs needed
The Government is expected to spend around £375m a year on new Covid vaccines after the stockpile bought during the pandemic ...